HomeTenants' Union of NSW
Reference Library Catalogue

Management of clandestine drug laboratories : (Record no. 386)

MARC details
000 -LEADER
fixed length control field 02490nam a22002057a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230627153432.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210622b |||||||| |||| 00| 0 eng d
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 347
Personal name Al-Obaidi, Tamara A.
245 ## - TITLE STATEMENT
Title Management of clandestine drug laboratories :
Remainder of title need for evidence-based environmental health policies
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Environ Health Prev Med,
Date of publication, distribution, etc. 2014.
300 ## - PHYSICAL DESCRIPTION
Extent 11 pages
500 ## - GENERAL NOTE
General note KEYWORDS: Illegal drug labs
520 ## - SUMMARY, ETC.
Summary, etc. Clandestine drug laboratories (CDLs) have been emerging and increasing as a public health problem in Australia, with methamphetamine being the dominant illegally manufactured drug. However, management and remediation of contaminated properties are still limited in terms of regulation and direction, especially in relation to public and environmental health practice. Therefore, this review provides an update on the hazards and health effects associated with CDLs, with a specific look at the management of these labs from an Australian perspective. Particularly, the paper attempts to describe the policy landscape for management of CDLs, and identifies current gaps and how further research may be utilised to advance understanding and management of CDLs and inform public health policies. The paper highlights a significant lack of evidence-based policies and guidelines to guide regulatory authority including environmental health officers in Australia. Only recently, the national Clandestine Drug Laboratory Guidelines were developed to assist relevant authority and specialists manage and carry out investigations and remediation of contaminated sites. However, only<br/>three states have developed state-based guidelines, some of which are inadequate to meet environmental health requirements. The review recommends well-needed intersectoral collaborations and further research to provide an evidence base for the development of robust policies and<br/>standard operating procedures for safe and effective environmental health management and remediation of CDLs.
524 ## - PREFERRED CITATION OF DESCRIBED MATERIALS NOTE
Preferred citation of described materials note CITATION: Al-Obaidi, Tamara A, and Stephanie M Fletcher. “Management of clandestine drug laboratories: need for evidence-based environmental health policies.” Environmental health and preventive medicine vol. 19,1 (2014): 1-11. doi:10.1007/s12199-013-0360-8
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Health & Comfort
Geographic subdivision Australia
9 (RLIN) 498
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 348
Personal name Fletcher, Stephanie M.
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://pubmed.ncbi.nlm.nih.gov/24002745/">https://pubmed.ncbi.nlm.nih.gov/24002745/</a>
Link text View item on publishers website
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Article
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Use restrictions Not for loan Home library Current library Date acquired Date last seen Uniform Resource Identifier Price effective from Koha item type
No   Dewey Decimal Classification No Yes No tunsw tunsw 22/06/2021 22/06/2021 https://cfiles.tenantsunion.org.au/f/1498 22/06/2021 Article
No   Dewey Decimal Classification No   No tunsw tunsw 22/06/2021 22/06/2021 https://pubmed.ncbi.nlm.nih.gov/24002745/ 22/06/2021 Article